Investor Overview

Webcast ImageWebcast
Q4 2009 Elan Corporation, plc Earnings Conference Call (Live)
02/10/10 at 8:30 a.m. ET
Q4 2009 Elan Corporation, plc Earnings Conference Call
Wednesday, February 10, 2010 8:30 a.m. ET  
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Company Overview:

 

Elan is a neuroscience-based biotechnology company headquartered in Dublin, Ireland. It was incorporated as a private limited company in December 1969 and became a public limited company in January 1984. Elan’s principal research and development, manufacturing and marketing facilities are located in Ireland and the United States.

Elan is organized into two business units: Biopharmaceuticals and Elan Drug Technologies.

Biopharmaceuticals includes research, development, and commercial activities for neurodegenerative diseases and autoimmune diseases. Elan Drug Technologies is a specialty pharmaceutical business, including specialized drug delivery and manufacturing.

What's New:

 
2008 Annual Report

Stock Quote:

 
ELN (ADS Common)
PriceChange% ChangeVolume
$6.97 - 0.182.52%1,188,100
Previous CloseToday's OpenIntraday HighIntraday Low
$7.15$7.11$7.15$6.89
02/08/10 4:00 p.m. ET
Minimum 20 minute delay

Recent Financial News:

More >>

 
27 January 2010
Elan Announces Webcast of Fourth Quarter and Full Year 2009 Financial Results
DUBLIN, Jan 27, 2010 (BUSINESS WIRE) -- Elan Corporation, plc (NYSE: ELN) announced today that it will host a conference call on Wednesday, February 10, at 8:30 a.m. Eastern Time (ET), 1:30 p.m. GMT with the investment community to discuss Elan's fourth quarter and full year 2009 financial results, which will be released before the European and U.S. financial markets open. Live audio of the conference call will be simultaneously broadcast over the Interne... 
25 January 2010
Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA(TM) (Dalfampridine) Extended Release Tablets
AMPYRA(TM) APPROVED USING ELAN'S PROPRIETARY MXDAS(TM) (MATRIX DRUG ABSORPTION SYSTEM) DRUG DELIVERY TECHNOLOGYDUBLIN, Ireland, Jan 25, 2010 (BUSINESS WIRE) -- Elan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) today issued the following statement regarding the U.S. Food and Drug Administration (FDA) approval of AMPYRA(TM) (dalfampridine) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by ... 
11 January 2010
World-Renowned Yogi Baron Baptiste Unveils New Program to Help People with Multiple Sclerosis
-- My MS Yoga is designed to help people better manage one of the most common neurological disorders, which often strikes in the prime of life --CAMBRIDGE, Mass., Jan 11, 2010 (BUSINESS WIRE) -- Baron Baptiste, bestselling author and founder of Baptiste Power Vinyasa Yoga, and Dr. Elliot Frohman, one of the world's leading authorities on multiple sclerosis (MS), have teamed up to develop My MS Yoga, a new program created especially for people with multiple sclerosis. My MS Yoga is an at-home exe... 
05 January 2010
Elan to Present at the 2010 J.P. Morgan Healthcare Conference
DUBLIN, Jan 05, 2010 (BUSINESS WIRE) -- Elan Corporation, plc (NYSE: ELN) today announced that it will present at the 28th Annual J.P. Morgan Healthcare Conference, on Wednesday, January 13, 2010, at 9:00 a.m. Pacific Time, noon Eastern Time and 5:00 p.m. GMT. Interested parties may access a live audio web cast of the presentation by visiting the Investor Relations section of the Elan website at http://www.elan.com, then clicking on the event icon. Following the live webcast, an archived versi... 

Upcoming Events:

More >>

 
Q4 2009 Elan Corporation, plc Earnings Conference Call
Wednesday, February 10, 2010 8:30 a.m. ET


Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Elan Corporation, PLC posts new information to the site. Just enter your e-mail address and click Submit.
 
Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
Designed and powered by Dow Jones Client Solutions
Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.

RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts Contact IR